Westfield Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$163M |
| 2 |
Caterpillar
CAT
|
+$85.4M |
| 3 |
Analog Devices
ADI
|
+$53.7M |
| 4 |
Advance Auto Parts
AAP
|
+$39.7M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$37.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$142M |
| 2 |
Costco
COST
|
+$77.5M |
| 3 |
Vail Resorts
MTN
|
+$76.9M |
| 4 |
CELG
Celgene Corp
CELG
|
+$73.2M |
| 5 |
Mettler-Toledo International
MTD
|
+$67.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.26% |
| 2 | Healthcare | 16.35% |
| 3 | Consumer Discretionary | 13.11% |
| 4 | Industrials | 12.97% |
| 5 | Financials | 10.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
State Street SPDR S&P 500 ETF Trust
SPY
$823B
| – | – |
-1,980
| Closed | -$495K |
|
|
LGF.A
277
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| – | – |
-27,795
| Closed | -$447K |
|
|
TMX
278
DELISTED
Terminix Global Holdings, Inc.
TMX
| – | – |
-675,340
| Closed | -$24.8M |
|
|
XLNX
279
DELISTED
Xilinx Inc
XLNX
| – | – |
-208,484
| Closed | -$17.8M |
|
|
CMD
280
DELISTED
Cantel Medical Corporation
CMD
| – | – |
-210,226
| Closed | -$15.7M |
|
|
FLIR
281
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| – | – |
-769,293
| Closed | -$33.5M |
|
|
ZAYO
282
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| – | – |
-1,196,330
| Closed | -$27.3M |
|
|
HF
283
DELISTED
HFF Inc.
HF
| – | – |
-541,847
| Closed | -$18M |
|
|
CELG
284
DELISTED
Celgene Corp
CELG
| – | – |
-1,142,913
| Closed | -$73.2M |
|
Similar funds
Westfield Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Westfield Capital Management held 284 positions worth $13.1B, up 12% from $11.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Westfield Capital Management withdrew a net $642M in Q1 2019, closing 38 positions and reducing 142 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Westfield Capital Management opened a new position in Bristol-Myers Squibb worth $156M.
- Westfield Capital Management's largest Q1 2019 buy was Bristol-Myers Squibb: 3,278,241 shares worth $156M.
- Westfield Capital Management added most to T-Mobile US in Q1 2019, an estimated $32.3M increase.
- Westfield Capital Management's biggest Q1 2019 reduction was Vail Resorts, cutting an estimated $76.9M.
- Westfield Capital Management fully exited Jazz Pharmaceuticals in Q1 2019, selling an estimated $142M.
- Westfield Capital Management's ten largest holdings make up 19% of its $13.1B portfolio in Q1 2019.
- Westfield Capital Management opened 44 new positions and closed 38 in Q1 2019.
- Westfield Capital Management's portfolio value rose 12% quarter-over-quarter to $13.1B.
Based on Westfield Capital Management's 13F filing for Q1 2019, filed 14 May 2019.